Group I Paks as therapeutic targets in <i>NF2</i>-deficient meningiomaHoi-Yee Chow, Jonathan Chernoff|Oncotarget|2015Cited by 48
Development and utility of a PAK1-selective degraderHoi-Yee Chow, Jonathan Chernoff|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 2